References
- Franks S. Polycystic ovary syndrome. N Engl J Med. 1995; 333: 853–61
- Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ. 1988; 297: 1024–6
- Jakubowicz DJ, Essah PA, Seppala M, Jakubowicz S, Baillargeon JP, Koistinen R, et al. Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy. J Clin Endocrinol Metab 2004; 89: 833–9
- Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006; 12: 673–83
- Marasco L, Marmet C, Shell E. Polycystic ovary syndrome: a connection to insufficient milk supply?. J Hum Lact. 2000; 16: 143–8
- Carlsen SM, Romundstad P, Jacobsen G. Early second trimester hyperandrogenemia and subsequent preeclampsia: A prospective study. Acta Obstet Gynecol Scand. 2004; 84: 117–21
- Leeners B, Rath W, Kuse S, Neumaier-Wagner P. Breast-feeding in women with hypertensive disorders in pregnancy. J Perinat Med. 2005; 33: 553–60
- Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F. Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod. 2002; 17: 2573–9
- Biggs JS, Hacker N, Andrews E, Munro C. Bromocriptine, methyl testosterone and placebo for inhibition of physiological lactation: a controlled study. Med J Aust. 1978; 2: 23–5
- De Gezelle H, Dhont M, Thiery M, Parewyck W. Puerperal lactation suppression and prolactin. Acta Obstet Gynecol Scand. 1979; 58: 469–72
- Kochenour NK. Lactation suppression. Clin Obstet Gynecol. 1980; 23: 1045–59
- Consensus: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.
- Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod. 2004; 19: 1734–40
- Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS. How many child deaths can we prevent this year?. Lancet. 2003; 362: 65–71
- Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ, et al. Breastfeeding and the use of human milk. Pediatrics. 2005; 115: 496–506
- WHO Report. Global strategy for infant and young child feeding, the optimal duration of exclusive breastfeeding. WHO, 2001.
- Rogers IS, Emmett PM, Golding J. The incidence and duration of breast feeding. Early Hum Dev. 1997; 49Suppl: S45–S74
- Scott JA, Binns CW. Factors associated with the initiation and duration of breastfeeding: a review of the literature. Breastfeed Rev. 1999; 7: 5–16
- Lande B, Andersen LF, Baerug A, Trygg KU, Lund-Larsen K, Veierod MB, et al. Infant feeding practices and associated factors in the first six months of life: the Norwegian infant nutrition survey. Acta Paediatr. 2003; 92: 152–61
- Kletzky OA, Marrs RP, Howard WF, McCormick W, Mishell DR, Jr. Prolactin synthesis and release during pregnancy and puerperium. Am J Obstet Gynecol. 1980; 136: 545–50
- McNeilly AS, Robinson IC, Houston MJ, Howie PW. Release of oxytocin and prolactin in response to suckling. Br Med J (Clin Res Ed) 1983; 286: 257–9
- Labrie F. Dehydroepiandrosterone, androgens and the mammary gland. Gynecol Endocrinol. 2006; 22: 118–30
- Barker DJ. The intrauterine origins of cardiovascular disease. Acta Paediatr Suppl 1993; 82(Suppl 391)93–9
- Barker DJ. Fetal origins of coronary heart disease. Br Heart J. 1993; 69: 195–6